Smuggling drugs across the blood-brain barrier

The blood-brain barrier is nature's way of making sure only authorized personnel enter our body's command center, much to the frustration of drug developers who would love to storm the gates and attack neurological diseases such as Alzheimer's and Parkinson's where they live. One overused, but appropriate, metaphor for a clever way of bypassing the BBB is the "Trojan Horse" method. Materials Views tells us about a research team in China that is using choline, a molecule abundant in the central nervous system, to smuggle drugs over the border. They're coupling choline with a nanoparticle gene-delivery system. Article

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.